Rising Healthcare Costs for Employers Amidst Economic Challenges
Healthcare costs for U.S. employers are set to soar significantly by 2027, threatening budgets despite proactive measures, an alarming trend according to the latest WTW survey.
As healthcare expenses continue escalating, employers are grappling with financial constraints that are more intense than any time in the last decade. The WTW's 2026 Best Practices in Healthcare Survey of 471 employers reveals that most companies have already surpassed their healthcare cost targets, with expenses overshooting budgets by an average of 5.6 percentage points in 2025. This landscape is creating profound concerns for employers and insurance professionals alike, as plans designed to control costs are still projecting heightened expenditures.
Factors Driving the Surge in Costs
Jeff Levin-Scherz from WTW pinpoints several factors contributing to the spike in costs, including medical innovations, inflation in provider fees, and consolidation within the healthcare provider sector. These structural challenges underscore the complex environment insurers must navigate. Levin-Scherz notes that while advances in medical treatment offer significant benefits, they also drive up costs that employers must manage, particularly as the healthcare landscape evolves.
Implications for Employers and Coverage Plans
The survey underscores a financial strain that many employers expect to persist for several years. This is prompting companies to reassess their health plan designs, with a notable 85% planning or considering increases in employee premium contributions by 2028. Similarly, out-of-pocket costs are expected to rise significantly. These changes are pivotal for insurance professionals who must balance coverage adequacy and affordability while navigating contractual and regulatory frameworks.
An additional concern is the potential impact on lower-wage employees, who might face disproportionate exposure to increased costs. Levin-Scherz advises employers to leverage data analytics to evaluate potential adverse effects on this subgroup to mitigate the risk of financial insecurity due to healthcare expenses.
Managing Vendor Relationships and PBM Scrutiny
With healthcare spending increasingly scrutinized, it's vital for employers and insurers to optimize vendor contracts. Interestingly, although employers maintain relationships with around 13 health-related vendors, only a minority evaluate clinical and financial impacts thoroughly. Rigorous assessments are recommended to ensure these programs deliver tangible value.
Medical costs have increased due to a combination of structural issues.
Pharmacy Benefit Managers (PBMs) are also under the microscope due to rising dissatisfaction. A significant 64% of employers are considering changes, such as seeking competitive bids, to mitigate costs, especially concerning high-expense pharmaceuticals like specialty drugs and GLP-1 medications for weight loss.
Regulatory Developments and Future Outlook
State and federal regulatory efforts might relieve some financial pressure. States like Indiana and Delaware are leading with bills to cap hospital charges relative to Medicare rates. Federally, there's the potential for bipartisan advancements on PBM regulation, which could reshape how these entities operate and support employers in managing pharmaceutical expenses.
| Factor | Impact |
|---|---|
| Medical Innovations | Increased treatment costs; benefits versus budget constraints |
| Provider Costs | Inflation driving up expenses |
| Consolidation | Fewer choices may lead to higher pricing |
As the Centers for Medicare & Medicaid Services (CMS) continues to refine guidelines tied to the No Surprises Act, insurance professionals should prepare for the 2027 renewal season. Adjustments in regulation, particularly around arbitration, may moderate cost pressures, enabling more favorable plan structuring. Although these measures will not solve the underlying cost issues entirely, they present opportunities to alleviate some financial burden.